Home Top Movers What Led The AKUS Stock To Increase On Thursday?

What Led The AKUS Stock To Increase On Thursday?

In its Thursday trading session, Akouos Inc. (NASDAQ: AKUS) rose by 8.08%, or $1.16, compared with its previous market close price. The lowest price the Akouos stock touched during the day was $14.37, while the day’s peak was $15.95.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Based on Barchart’s data, AKUS closed at $14.36 during the previous trading session, while the volume traded was 88075.0. The AKUS stock has soared as this week the company announced a couple of positive developments with respect to its leading candidate.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


  Read More

What were the recent moves?

Acouos is committed to bringing the benefits of genomic medicine to people around the world who suffer from hearing loss by developing gene therapies which could be used to restore, improve, and preserve high-acuity physiologic hearing.

AKUS has developed a precise genetic therapy platform that integrates a proprietary AAV vector library and a novel delivery strategy that allow it to develop precision therapies for various forms of sensory-nerve degeneration.

This week AKUS announced that its lead product, AK-OTOF was granted Orphan Drug Designation (ODD) as well as Rare Pediatric Disease Designation (RPDD) by the U.S. Food and Drug Administration (FDA).

AK-OTOF is a gene therapy meant for patients who already have otoferlin gene-mediated hearing loss. An investigational new drug application (IND) for AK-OTOF is expected to be submitted during the first half of 2022 by AKUS.

What does this mean for AKUS?

Being designated an ODD allows AKUS to qualify for a number of benefits, including seven years of post-approval market exclusivity, assistance in the drug development process, tax credits for clinical testing, and exemptions from FDA fees.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Under the Priority Review Voucher program, Akouos (AKUS) may be eligible to receive a voucher in case FDA approves AK-OTOF to treat OTOF-mediated hearing loss. By redeeming the voucher, AKUS may request priority review for a new marketing application for another product or it may sell the voucher to another sponsor.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Ambev S.A. (ABEV) Stock Trends Up Following Highly Promising Earnings Call for Q4 2020

Ambev S.A. (ABEV) stock prices were up 10.3943% shortly after the market opened on May 6th, 2021, bringing the price per share up to...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Related News

Himax Technologies, Inc. (HIMX) Stock Climbing After Promising Q1 2021 Financial Reports

Himax Technologies, Inc. (HIMX) stock prices were down by 6.97% as of the market closing on May 5th 2021, bringing the price per share...

Why BioCryst Pharmaceuticals, Inc. (BCRX) stock is climbing today?

BioCryst Pharmaceuticals, Inc. (BCRX) announced its first-quarter 2021 financial results after which the BCRX stock happened to be green as its per-share price went...

Precipio, Inc. (PRPO) Stock Trending Up Following Successful Launch of Covid-19 Antibody Testing Kit

Precipio, Inc. (PRPO) stock prices were down 3.62% as of the market closing on ay 5th 2021, bringing the price per hare down to...

Shares of Cinedigm Corp. (CIDM) are climbing high in the premarket. What’s Going On?

Cinedigm (NASDAQ:CIDM), a distributor of various movies, television and other digital content, managing a library of distribution rights to several thousand titles and different...

Why Stealth BioTherapeutics Corp (MITO) stock is soaring in Pre-Market today?

Stealth BioTherapeutics Corp (MITO) presented the data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting, which is collected...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.